Pharma Pricing & Market Access
· Singapore · Pharma
Pricing strategy, HTA and market access for pharma across emerging Asia.
About the event
Pharma Pricing & Market Access is the leading conference for pricing, access and health-economics professionals covering the Asian growth markets. The conference covers reference pricing and IRP, value-based contracting, patient-access programmes, HTA submission strategy across China NMPA / NRDL, Korea HIRA, Taiwan CDE and the Southeast Asian access pathways.
Who should attend
- Heads of Pricing, Market Access and HEOR at pharma companies
- Pricing and access consultants serving the Asia-Pacific markets
- Payers, HTA agencies and ministry-of-health officials
- Patient-organisation leadership and patient-access programme partners
Why attend
- Hear payer and HTA perspective across China, Korea and SEA
- Benchmark pricing and access strategies for high-cost innovation
- Build patient-access programmes that scale across multiple markets
- Engage policy makers on the reimbursement and access trajectory
Agenda highlights
- Day 1: Asia pricing & access outlook — country snapshots
- Day 1: China NRDL deep dive — strategy and case studies
- Day 2: Korea HIRA and value-based contracting in Asia
- Day 2: Patient-access programmes and creative reimbursement
Sponsorship and partnership
Sponsorship, exhibition and partnership opportunities are available across speaking, branding and lead-generation packages. Get in touch through the event registration link to receive the sponsorship prospectus.
Registration and contact
Registration details for Pharma Pricing & Market Access will be announced. Group rates and team passes are usually available; sponsorship and exhibition opportunities can be requested directly from the organiser.